- ASML has maintained its net sales forecast for 2025, projecting a range of EUR 30 billion to EUR 35 billion.
- The company estimates its net sales to be approximately EUR 32.56 billion in 2025.
- ASML anticipates that export restrictions will not significantly impact its business in 2024.
- By 2025, sales from the Chinese market are expected to account for about 20% of ASML’s total net sales.
- Looking towards 2030, ASML foresees potential annual net sales scenarios ranging from EUR 44 billion to EUR 60 billion.
- The company is currently evaluating the potential effects of new US regulations on its operations.
- In terms of market recommendations, ASML currently holds 30 buy ratings, 10 hold ratings, and no sell ratings.
A look at ASML Holding NV Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
ASML Holding NV, a leading semiconductor manufacturing equipment company, has received positive Smart Scores across various key factors. With strong scores in Growth and Resilience, ASML Holding NV is poised for long-term success in the industry. The company’s focus on innovation and steady performance in the face of challenges bode well for its future prospects.
Although ASML Holding NV scores are not the highest across all categories, its solid performance in Growth and Resilience indicate a stable outlook. As the company continues to cater to clients worldwide with its cutting-edge lithography machines for chip production, investors can consider ASML Holding NV as a company with growth potential and resilience in the ever-evolving semiconductor market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
